Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Filings indexed 861 across all filing types
Latest filing 2021-11-08 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Interim / Quarterly Report Classification · 100% confidence The document is a detailed communication from Wockhardt Limited to stock exchanges regarding the outcome of a Board Meeting held on 8th November 2021. It includes approval of unaudited financial results for the quarter and half year ended 30th September 2021, along with the Limited Review Report by the statutory auditors. The document contains actual financial data, including income, expenses, and loss figures for the period, and the auditor's review report. The presence of unaudited financial results and the limited review report indicates this is an Interim / Quarterly Report. The document is about half-year and quarterly financial results, not a full annual report or just an announcement. Therefore, the correct classification is Interim / Quarterly Report (IR).
2021-11-08 English
Press Release
Interim / Quarterly Report Classification · 100% confidence The document is a detailed communication from Wockhardt Limited to stock exchanges regarding the outcome of a Board Meeting held on 8th November 2021. It includes approval of unaudited financial results for the quarter and half year ended 30th September 2021, along with the Limited Review Report by the statutory auditors. The document contains actual financial data, including income, expenses, and loss figures for the period, and the auditor's review report. The presence of substantive financial statements and analysis for a period shorter than a full fiscal year (quarter and half year) indicates this is an Interim / Quarterly Report. It is not merely an announcement or certification but includes detailed financial results and auditor review, fitting the definition of an Interim / Quarterly Report (IR).
2021-11-08 English
Outcome of Board Meeting
Regulatory Filings
2021-11-08 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled Board of Directors meeting to consider and approve unaudited financial results for the quarter and half year ended 30th September 2021. It also mentions the trading window closure period. The document does not contain any financial data or results itself, nor does it attach or provide the actual financial report. It is an announcement about an upcoming event related to financial results, not the results or report itself. The length is only 1361 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about a board meeting and trading window closure, without substantive financial data or report content.
2021-11-01 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a detailed disclosure under Regulation 31(1) and 31(3) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, concerning the creation of pledge on equity shares held by promoters in Wockhardt Limited. It includes extensive tabular data about share encumbrances, promoters, pledge details, and related entities. The document is a regulatory disclosure about changes in share encumbrance and substantial acquisition of shares, which fits the definition of a Major Shareholding Notification (MRQ). It is not an annual report, earnings release, or any other financial report type. It is also not a simple announcement or certification but a substantive regulatory filing about shareholding changes. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2021-10-22 English
Allotment of Securities
Capital/Financing Update Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the allotment of unlisted rated secured non-convertible debentures (NCDs) on a private placement basis. It references compliance with SEBI Listing Regulations and provides detailed disclosure about the issuance, including the number of securities, issue size, tenure, coupon rate, security charge, and redemption schedule. The document is an announcement of a financing activity related to the company's capital structure, specifically the issuance of debt securities. It does not contain financial statements or comprehensive financial performance data, nor is it a report or transcript. The document length is 4158 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-10-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.